Profil
Thomas Schäfer is currently a Director at Bioinnovation Institute and BacThera AG.
He was previously the Head of Business Development at Novozymes A. From 2017 to 2022, he served as the Chief Scientific Officer and Executive VP at Chr.
Hansen Holding A. Schäfer holds a doctorate degree from Freie Universität Berlin.
Senaste nyheterna om Thomas Schäfer
Aktiva positioner av Thomas Schäfer
| Företag | Position | Start |
|---|---|---|
Bioinnovation Institute
Bioinnovation Institute Investment ManagersFinance BioInnovation Institute invests in companies located in Europe. The firm targets companies operating in technology sectors such as therapeutics, health tech, planetary health and quantum tech. It provides financing for early stage capital requirements with an investment size ranging from DKK 7.86 to 14 million. | Direktör/Styrelseledamot | - |
BacThera AG
BacThera AG Pharmaceuticals: MajorHealth Technology Manufactures bio therapeutic products | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Thomas Schäfer
| Företag | Position | Slut |
|---|---|---|
| CHRISTIAN HANSEN | Teknisk/Vetenskaplig/F&U Direktör | 2022-03-31 |
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Företagsledare/Principal | - |
Thomas Schäfers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Process Industries |
Freie Universität Berlin
Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chr. Hansen Holding A/S
Chr. Hansen Holding A/S Food: Specialty/CandyConsumer Non-Durables Manufactures food cultures, enzymes and nutrition products | Consumer Non-Durables |
Bioinnovation Institute
Bioinnovation Institute Investment ManagersFinance BioInnovation Institute invests in companies located in Europe. The firm targets companies operating in technology sectors such as therapeutics, health tech, planetary health and quantum tech. It provides financing for early stage capital requirements with an investment size ranging from DKK 7.86 to 14 million. | Finance |
BacThera AG
BacThera AG Pharmaceuticals: MajorHealth Technology Manufactures bio therapeutic products | Health Technology |
















